Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: RAMM Pharma Corp.

Market Cap 1.79M 1.28M 1.11M 1.02M 956K 122M 1.82M 12.05M 4.7M 59.34M 4.81M 4.71M 205M P/E Ratio 2024
-0.07x
P/E Ratio 2025 -0.2x
Enterprise Value 1.07M 764K 660K 608K 570K 72.66M 1.08M 7.18M 2.8M 35.37M 2.87M 2.81M 122M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
6 months-40.00%
Current year-75.00%
1 month 0.01
Extreme 0.01
0.02
Current year 0.01
Extreme 0.01
0.05
1 year 0.01
Extreme 0.01
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
1
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Date Insider Type Main position Quantity % Market Cap.
25-06-01Sell

Chief Executive Officer

4,667,000 3.9091%
25-03-20Buy

Chief Executive Officer

100,000 0.0838%
25-03-20Buy

Chief Executive Officer

200,000 0.1675%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-70.00% 1.28M
-2.41%+0.14%+38.28%+154.20% 1,010B
+1.07%+3.48%+53.32%+49.85% 580B
+1.32%+0.22%+19.18%+64.65% 402B
+0.77%0.00%+21.28%+16.70% 330B
+0.44%+3.48%+25.65%+35.66% 281B
-0.85%-2.86%+22.54%+14.67% 280B
+1.66%+1.20%-44.35%-47.35% 197B
+0.32%+1.61%+20.32%+60.01% 192B
-0.22%-2.76%+14.19%+60.09% 156B
Average +0.21%+0.76%+22.04%+33.85% 342.89B
Weighted average by Cap. -0.23%+1.04%+27.77%+70.54%

Financials

2024 2025
Net sales 4.34M 3.11M 2.69M 2.48M 2.32M 296M 4.41M 29.23M 11.39M 144M 11.67M 11.42M 498M 3.36M 2.41M 2.08M 1.92M 1.79M 229M 3.41M 22.62M 8.82M 111M 9.03M 8.84M 386M
Net income -16.5M -11.82M -10.21M -9.41M -8.81M -1.12B -16.76M -111M -43.31M -547M -44.36M -43.41M -1.89B -8.91M -6.38M -5.51M -5.08M -4.75M -607M -9.05M -59.97M -23.38M -295M -23.95M -23.44M -1.02B
Net Debt -626K -448K -387K -357K -334K -42.6M -635K -4.21M -1.64M -20.73M -1.68M -1.65M -71.79M -723K -518K -448K -412K -386K -49.25M -735K -4.87M -1.9M -23.97M -1.94M -1.9M -83.01M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!